Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Modular vaccine platform based on the norovirus-like particle

by Lampinen, Vili , Blazevic, Vesna , Laitinen, Olli H. , Hankaniemi, Minna M. , Hytönen, Vesa P. , Pesu, Marko , Heinimäki, Suvi

in Biotechnology / Chemistry / Chemistry and Materials Science / Evaluation / Genetic aspects / Immune response / Influenza / Influenza vaccines / Molecular Medicine / Nanotechnology / Norovirus / SpyCatcher / Vaccine / Virus / VLP

2021

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Modular vaccine platform based on the norovirus-like particle

by Lampinen, Vili , Blazevic, Vesna , Laitinen, Olli H. , Hankaniemi, Minna M. , Hytönen, Vesa P. , Pesu, Marko , Heinimäki, Suvi

2021

Confirm

Do you wish to request the book?

Modular vaccine platform based on the norovirus-like particle

by Lampinen, Vili , Blazevic, Vesna , Laitinen, Olli H. , Hankaniemi, Minna M. , Hytönen, Vesa P. , Pesu, Marko , Heinimäki, Suvi

2021

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Modular vaccine platform based on the norovirus-like particle

Lampinen, Vili,

Blazevic, Vesna,

Laitinen, Olli H.,

Hankaniemi, Minna M.,

Hytönen, Vesa P.,

Pesu, Marko,

Heinimäki, Suvi

2021

Overview

Background Virus-like particle (VLP) vaccines have recently emerged as a safe and effective alternative to conventional vaccine technologies. The strong immunogenic effects of VLPs can be harnessed for making vaccines against any pathogen by decorating VLPs with antigens from the pathogen. Producing the antigenic pathogen fragments and the VLP platform separately makes vaccine development rapid and convenient. Here we decorated the norovirus-like particle with two conserved influenza antigens and tested for the immunogenicity of the vaccine candidates in BALB/c mice. Results SpyTagged noro-VLP was expressed with high efficiency in insect cells and purified using industrially scalable methods. Like the native noro-VLP, SpyTagged noro-VLP is stable for months when refrigerated in a physiological buffer. The conserved influenza antigens were produced separately as SpyCatcher fusions in E. coli before covalent conjugation on the surface of noro-VLP. The noro-VLP had a high adjuvant effect, inducing high titers of antibody production against the antigens presented on its surface. Conclusions The modular noro-VLP vaccine platform presented here offers a rapid, convenient and safe method to present various soluble protein antigens to the immune system for vaccination and antibody production purposes.

Share this book

Add to My Shelf

Publisher

BioMed Central,BioMed Central Ltd,BMC

Subject

Biotechnology

/ Chemistry

/ Chemistry and Materials Science